This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.
Clinical trial NCT00032903 · COMPLETED
Trial details
- NCT number
- NCT00032903
- Sponsor
- Sigma-Tau Research, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.